Clinical Trials Logo

Clinical Trial Summary

This is a a Simon's two-stage, non-randomized, open label, 2-arm Phase II trial of ONC201 in women with metastatic or recurrent Type II endometrial cancer who failed at least 1 prior chemotherapy regimen.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03485729
Study type Interventional
Source Chimerix
Contact
Status Active, not recruiting
Phase Phase 2
Start date March 21, 2018
Completion date December 31, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT05001282 - A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRĪ±) Phase 1/Phase 2
Recruiting NCT04030429 - Crizotinib in c-MET Mutation Metastatic/Recurrent/Persistent Endometrial Cancer Phase 2
Recruiting NCT03621904 - PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer
Recruiting NCT02922764 - A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer Phase 1
Recruiting NCT05410717 - CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors Phase 1
Completed NCT03015129 - A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer Phase 2